CET | Jotup

Biophytis announces receipt of Nasdaq Notice

Retrieved on:

Thursday, December 14, 2023

Letter, Patient, CET, Ageing, Therapy, Euronext Growth

The Notification Letter has no immediate effect on the listing of the ADSs, and they will continue to trade on The Nasdaq Global Select Market under the symbol “BPTS”.

Key Points:

The Notification Letter has no immediate effect on the listing of the ADSs, and they will continue to trade on The Nasdaq Global Select Market under the symbol “BPTS”.
Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the applicable grace period to regain compliance is 180 days, or until May 13, 2024.
Biophytis intends to regain compliance within the applicable compliance period and is currently evaluating its options to do so.
During this time, the Company’s ADSs will continue to be listed and trade on The Nasdaq Global Select Market and the Company’s business and operations are not affected by the receipt of the Notification Letter.

EQS-News: Infineon achieves record revenue and earnings in the 2023 fiscal year and expects further revenue growth to € 17 billion and a Segment Result Margin of 24 percent for 2024

Retrieved on:

Thursday, December 14, 2023

The gross margin in the fourth quarter was 43.6 percent, compared with 44.5 percent in the third quarter of the 2023 fiscal year.

Key Points:

The gross margin in the fourth quarter was 43.6 percent, compared with 44.5 percent in the third quarter of the 2023 fiscal year.
The Segment Result in the fourth quarter of the 2023 fiscal year was €1,044 million, compared with €1,067 million in the previous quarter.
Operating profit for the fourth quarter of the 2023 fiscal year was €912 million, compared with €996 million in the third quarter.
The tax expense in the fourth quarter of the 2023 fiscal year was €163 million, compared with €167 million in the preceding quarter.

EQS-News: Brockhaus Technologies AG: Extension of Offer Period of Share Buyback Offer

Retrieved on:

Thursday, December 14, 2023

Federal Financial Supervisory Authority, ISIN, Federal Gazette (Switzerland), Person, Federal republic, CET, Communication, Share repurchase, Federal Gazette, Cryptocurrency

On November 22, 2023 Brockhaus Technologies AG (BKHT, ISIN: DE000A2GSU42, “Brockhaus Technologies” or "Company") has published a voluntary public share buyback offer to the shareholders of the Company for a total of up to 500,000 shares at a price of EUR 22.00 per share (the “Share Buyback Offer”).

Key Points:

On November 22, 2023 Brockhaus Technologies AG (BKHT, ISIN: DE000A2GSU42, “Brockhaus Technologies” or "Company") has published a voluntary public share buyback offer to the shareholders of the Company for a total of up to 500,000 shares at a price of EUR 22.00 per share (the “Share Buyback Offer”).
With reference to the Share Buyback Offer, the Company announces that the offer period of the Share Buyback Offer, which was initially to expire on December 4, 2023, has been extended until and including December 14, 2023, 24:00 (CET).
This announcement does not constitute an offer to purchase securities or the solicitation of an offer to purchase any securities of Brockhaus Technologies AG.
The share buyback offer does not comply with the requirements of the German Securities Acquisition and Takeover Act (WpÜG).

EQS-News: MGI – Media and Games Invest SE Invites Investors to the Presentation of its Interim Report Q3 2023 on November 30, 2023, at 10 am (CET)

Retrieved on:

Thursday, December 14, 2023

Remco, CET, ISIN, Interim, CFO, MGI, Media, Q3, Clothing

MGI – Media and Games Invest SE Invites Investors to the Presentation of its Interim Report Q3 2023 on November 30, 2023, at 10 am (CET)

Key Points:

MGI – Media and Games Invest SE Invites Investors to the Presentation of its Interim Report Q3 2023 on November 30, 2023, at 10 am (CET)
The issuer is solely responsible for the content of this announcement.
MGI – Media and Games Invest SE Invites Investors to the Presentation of its Interim Report Q3 2023 on November 30, 2023, at 10 am (CET)
November 23, 2023: MGI – Media and Games Invest SE (“MGI” or the “Company”, ISIN: SE0018538068; Ticker M8G; Nasdaq First North Premier Growth Market and Scale Segment Frankfurt Stock Exchange) will publish its Interim Report Q3 2023 on November 30, 2023, and invites investors to participate in the presentation of the Q3 results by Remco Westermann (CEO) and Paul Echt (CFO) on Thursday, November 30, 2023, at 10 am CET.
The presentation will be held in English and will also be available on-demand on the Company’s website www.mgi-se.com.

EQS-News: Abivax announces the resumption of its liquidity contract

Retrieved on:

Thursday, December 14, 2023

CET, Therapy, Euronext Paris, Patient, ADS, Security (finance), Cryptocurrency, Abivax

Paris, France, November 21, 2023 – 8:30 a.m. CET – Abivax SA (Euronext Paris and Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, announces the resumption, as of today, of its liquidity contract and the end of the stabilization period.

Key Points:

Paris, France, November 21, 2023 – 8:30 a.m. CET – Abivax SA (Euronext Paris and Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, announces the resumption, as of today, of its liquidity contract and the end of the stabilization period.
The liquidity contract was entered into with TSAF on June 26, 2015, and suspended in the context of the initial public offering of Abivax shares in the form of ADS on the Nasdaq Global Market.
Following the stabilization activities carried out since October 20, 2023, the stabilization period has ended on November 20, 2023.
As of November 20, 2023, the following means are allocated to the liquidity account for the execution of this contract:
11,257 Abivax shares held on behalf of Abivax,

EQS-News: Commerzbank lays foundation for further strategic plan with strong 9M net profit – targeting RoTE of more than 11% in 2027

Retrieved on:

Thursday, December 14, 2023

The Bank has almost achieved the key targets of its “Strategy 2024” and has laid a strong foundation for the targeted higher pay-out.

Key Points:

The Bank has almost achieved the key targets of its “Strategy 2024” and has laid a strong foundation for the targeted higher pay-out.
By 2027, the revenue base is to be further expanded through consistent customer orientation and profitability is to be continuously increased.
The Bank’s financial steering will continue to be based on the cost-income ratio, which is planned to improve to around 55% by 2027.
For 2022 to 2024, the plan is still to distribute a total of €3 billion to shareholders through dividends and share buy-backs.

EQS-News: Aurubis AG: Aurubis AG generates preliminary operating earnings before taxes (EBT) of € 349 million at upper end of most recent forecast and will release final fiscal year results on December 20, 2023

Retrieved on:

Thursday, December 14, 2023

Aurubis AG: Aurubis AG generates preliminary operating earnings before taxes (EBT) of € 349 million at upper end of most recent forecast and will release final fiscal year results on December 20, 2023

Key Points:

Aurubis AG: Aurubis AG generates preliminary operating earnings before taxes (EBT) of € 349 million at upper end of most recent forecast and will release final fiscal year results on December 20, 2023
The issuer is solely responsible for the content of this announcement.
Aurubis AG generates preliminary operating earnings before taxes (EBT) of € 349 million at upper end of most recent forecast and will release final fiscal year results on December 20, 2023
Hamburg, November 22, 2023 – According to preliminary results, the multimetal company generated operating earnings before taxes (EBT) of € 349 million in fiscal year 2022/23 (previous year: € 532 million).
This puts EBT at the upper end of the most recent forecast set at € 310 to 350 million for the past fiscal year.
Additional details and the final 2022/23 fiscal year results will be disclosed on December 20, 2023.

EQS-News: TERMS AND CONDITIONS OF A BUY-BACK OFFER BY THE COMPANY

Retrieved on:

Thursday, December 14, 2023

Publication, EUR, CPI Property Group, Countersign, CET, ISIN, Condition, Security (finance), Holding company, Medical device

It is intended that the shares acquired by the Company within the Offer will be cancelled afterwards through a share capital reduction.

Key Points:

It is intended that the shares acquired by the Company within the Offer will be cancelled afterwards through a share capital reduction.
Participating shareholder: only shareholders holding CPIPG shares on 19 November 2023 at 23:59 (CET time) can participate to the Offer.
Conditions of the Offer (the "Conditions"): The Company is willing to repurchase in the context of the Offer a maximum number of up to 105,000,000 CPIPG shares.
Terms of the Offer may be adjusted to address any comments formulated by regulatory authorities or stock exchange.

EQS-News: Formycon publishes nine-month results for 2023

Retrieved on:

Thursday, December 14, 2023

Preparations for the start of the clinical development program for the biosimilar candidate FYB206 (pembrolizumab) are already well advanced.

Key Points:

Preparations for the start of the clinical development program for the biosimilar candidate FYB206 (pembrolizumab) are already well advanced.
As expected, the Formycon Group's cash and cash equivalents amounted to around € 35.6 million as of September 30, 2023, compared to € 9.8 million as of December 31, 2022.
The conference call, which will be streamed live online, will be held in English on November 13, 2023 at 3:00 p.m. (CET).
The conference call will be recorded and will be available afterwards via the Formycon website at: https://www.formycon.com/investoren/fakten-zahlen/ .

EQS-News: GBC AG: Invitation to the 9th International Investment Forum (IIF) - [ONLINE] on December 5, 2023

Retrieved on:

Thursday, December 14, 2023

Hose, CET, Software, GBC, Politics, Travel, ONLINE

GBC AG: Invitation to the 9th International Investment Forum (IIF) - [ONLINE] on December 5, 2023

Key Points:

GBC AG: Invitation to the 9th International Investment Forum (IIF) - [ONLINE] on December 5, 2023
The issuer is solely responsible for the content of this announcement.
We invite you to participate online in the 9th International Investment Forum (IIF) on December 5, 2023 from 09:25 a.m. (CET).
For the ninth time since its launch in 2021, the IIF will now take place online and bring investors together with selected internationally oriented companies.
As a live online event, the International Investment Forum (IIF) offers direct access to national and international listed companies from Europe, Australia and North America.